This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Cannabidiol is showing promising results for the treatment of COVID-19, due to its capa- bility of acting on the unleashed cytokine storm, on the proteins necessary for both virus entry and replication and on the neurological consequences of patients who have been infected by the virus. Here, we summarize the latest knowledge regarding the advantages of using cannabinoids in the treatment of COVID-19.

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?

This work is a literature review, presenting the current state of the use of cannabinoids on neurodegenerative diseases. The emphasis is on Parkinson’s (PD) and Alzheimer’s (AD) diseases, the two most prevalent neurological diseases. The review goes from Cannabis sativa and its hundreds of bioactive compounds to Δ9-tetrahydrocannabinol (THC) and mainly cannabidiol (CBD) and their interactions with the endocannabinoid receptors (CB1 and CB2).

Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

Evidence suggests cannabidiol (CBD) has anxiolytic properties, indicating potential for novel treatment strategies. However, few clinical trials of CBD-based products have been conducted, and none thus far have examined the impact of these products on cognition.

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users.

Cannabinoids as Emergent Therapy Against COVID-19

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2(SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massiveimpact. Despite a fast development and implementation of vaccination strategies, and the scouting of severalpharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids repre-sent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. Thismini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far iden-tified for the treatment and prevention of COVID-19, finally considering key aspects related to their technologicaland clinical implementation.

Synergy with Cannabis and Other Herbs: Thinking Beyond Plant Constituents

Explore the different types of plant synergy, herbs that may combine well with cannabis, and the healing properties of botanicals that science will never be able to fully explain.

Tic Disorder Management with Cannabis: A Family’s Tale Meets the Science

Dr. Genevieve Newton describes the state of the research on cannabis in the treatment of tic disorders and what her young son’s experience with cannabis has been like.

Cannabis as a Multifaceted Treatment Approach to Alzheimer’s Disease

Current treatments cannot stop or reverse the progression of the Alzhiemer’s disease. Learn how cannabis medicine may be a valid treatment option to alleviate the multitude of complex symptoms associated with this condition.

Cannabis Use Leads to Heart Attacks? Healthcare Providers Set the Record Straight

In an effort to set the record straight on the questionable conclusions presented in a recent cannabis and heart attack risk study, SCC Board Members Sherry Yafai, MD and Patricia C. Frye, MD weigh in with their observations and research evidence.

Mothers Give Insight on Navigating Medical Cannabis for their Children with Autism

The Society of Cannabis Clinicians interviews mothers of children with autism about their journey and how cannabis has played a role.

Cannabis Education in Communities of Color: An Opportunity for Healthcare Professionals

Inequality exists in all aspects of society, including incarceration, policing, medicine, research, and the cannabis industry. It is the duty of healthcare workers to heal communities in need and critique systems that cause harm.

Cannabis Consciousness, Alternative Healing, and the Medicine of Psychoactivity

Dustin Sulak, DO on cannabis consciousness, plant ritual and its healing potential, the benefits of psychoactivity, and other entheogenic allies for our current times.